BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12480866)

  • 21. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic possibilities for acne vulgaris].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1998 May; 21(5):154-6. PubMed ID: 9617104
    [No Abstract]   [Full Text] [Related]  

  • 23. Propionibacterium acnes resistance: a worldwide problem.
    Eady EA; Gloor M; Leyden JJ
    Dermatology; 2003; 206(1):54-6. PubMed ID: 12566805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial resistance in French acne patients.
    Dumont-Wallon G; Moyse D; Blouin E; Dréno B
    Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human beta defensins: a new perspective in acne treatment?].
    Körber A; Lehnen M; Grabbe S; Dissemond J
    Dtsch Med Wochenschr; 2005 Feb; 130(5):210-2. PubMed ID: 15678389
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acne and its treatment possibilities].
    Böni R; Hafner J; Krasovec M
    Schweiz Med Wochenschr; 1999 Oct; 129(41):1496-503. PubMed ID: 10555254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are retinoid/antibiotic fixed-dose combination acne treatments associated with antibiotic resistance?
    Dréno B; Lambert J; Bettoli V
    Eur J Dermatol; 2016; 26(1):90-1. PubMed ID: 27023018
    [No Abstract]   [Full Text] [Related]  

  • 28. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance.
    Aubin GG; Portillo ME; Trampuz A; Corvec S
    Med Mal Infect; 2014 Jun; 44(6):241-50. PubMed ID: 24656842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance in acne treatment.
    Humphrey S
    Skin Therapy Lett; 2012 Oct; 17(9):1-3. PubMed ID: 23032935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.
    Patel M; Bowe WP; Heughebaert C; Shalita AR
    J Drugs Dermatol; 2010 Jun; 9(6):655-64. PubMed ID: 20645527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I
    Ann Dermatol Venereol; 1998 Dec; 125(12):879-80. PubMed ID: 9922858
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic resistance of propionibacteria. Four years' experience of a large number of cases in Italy.
    Bettoli V; Borghi A; Rossi R; Ferroni M; Rigolin F; Virgili A
    Dermatology; 2006; 212(2):206-7. PubMed ID: 16484831
    [No Abstract]   [Full Text] [Related]  

  • 36. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data.
    Del Rosso JQ
    Cutis; 2008 Nov; 82(5):336-42. PubMed ID: 19090337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 38. Treating acne with antibiotic-resistant bacterial colonization.
    Tzellos T; Zampeli V; Makrantonaki E; Zouboulis CC
    Expert Opin Pharmacother; 2011 Jun; 12(8):1233-47. PubMed ID: 21355786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ; Del Rosso JQ; Webster GF
    Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.